![](/img/cover-not-exists.png)
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer
Overman, M J, Adam, L, Raghav, K, Wang, J, Kee, B, Fogelman, D, Eng, C, Vilar, E, Shroff, R, Dasari, A, Wolff, R, Morris, J, Karunasena, E, Pisanic, T R, Azad, N, Kopetz, SVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy221
Date:
March, 2019
File:
PDF, 73 KB
2019